Transcript Intelligence: DBV Technologies at Guggenheim Emerging Outlook Biotech Summit
StreetAccount Summary - Trading higher/lower: EU mid-morning
DBV Technologies receives €166.7M from full exercise of warrants from March financing (€3.68, 0.00)
Powered by FactSet Research Systems Inc.